Advanced company searchLink opens in new window

SWANBIO THERAPEUTICS LIMITED

Company number 10942620

Persons with significant control: 1 active person with significant control / 0 active statements

Spur Therapeutics Holdings Limited Active

Correspondence address
Sycamore House, Gunnels Wood Road, Stevenage, United Kingdom, SG1 2BP
Notified on
19 March 2024
Governing law
Legal form
Place registered
Companies House
Registration number
15295548
Incorporated in
United Kingdom
Nature of control
Ownership of shares – 75% or more
Ownership of voting rights - More than 25% but not more than 50%
Right to appoint or remove directors

Syncona Limited Ceased

Correspondence address
PO BOX 255 Trafalgar Court, Les Banques, St Peter Port, Guernsey, GY1 3QL
Notified on
2 February 2018
Ceased on
19 March 2024
Governing law
Legal form
Place registered
Guernsey
Registration number
55514
Incorporated in
Guernsey
Nature of control
Ownership of shares – More than 50% but less than 75%
Ownership of voting rights - More than 50% but less than 75%
Right to appoint or remove directors

Rachel Lynn Salzman Ceased

Correspondence address
215 Euston Road, London, United Kingdom, NW1 2BE
Notified on
1 September 2017
Ceased on
2 February 2018
Date of birth
December 1959
Nationality
American
Country of residence
Usa
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%

Florian Sebald Eichler Ceased

Correspondence address
215 Euston Road, London, United Kingdom, NW1 2BE
Notified on
1 September 2017
Ceased on
2 February 2018
Date of birth
May 1967
Nationality
American
Country of residence
Usa
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%

Karen Fran Kozarsky Ceased

Correspondence address
215 Euston Road, London, United Kingdom, NW1 2BE
Notified on
1 September 2017
Ceased on
2 February 2018
Date of birth
July 1960
Nationality
American
Country of residence
Usa
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%